PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Oct-2024 CNX Therapeutics CEO Guy Clark Awarded “CEO of the Year” at CPHI Pharma Awards CNX Therapeutics
10-Oct-2024 Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Pharming Group
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Valneva Scotland supports local cancer charity Team Jak Foundation Valneva Scotland
10-Oct-2024 NICE lifts restriction and recommends bispecific antibody TECVAYLI®▼ (teclistamab) for all eligible patients with relapsed and refractory multiple myeloma after three treatments Johnson & Johnson
10-Oct-2024 Demonstrating the potential of flow biocatalysis Vapourtec
10-Oct-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab) SC-based quadruplet regimen for newly diagnosed multiple myeloma patients Johnson & Johnson
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis
10-Oct-2024 New Study Demonstrates Scalp Cooling Efficacy in Reducing Persistent Chemotherapy-Induced Alopecia Paxman
10-Oct-2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer FluoGuide A/S
10-Oct-2024 Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public GWI research
10-Oct-2024 Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer Curve Therapeutics
10-Oct-2024 Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687 Antag Therapeutics
10-Oct-2024 PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting PureTech Health plc
10-Oct-2024 Purespring Therapeutics raises £80 million in a Series B financing Syncona Ltd
10-Oct-2024 New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Sanofi
10-Oct-2024 Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer Driven by EGFR Exon 19 or 21 and Co-occurring C797S Mutations Pierre Fabre Laboratories
10-Oct-2024 ACG Accelerates European Growth with Major Expansion in Croatia ACG
10-Oct-2024 Vivanti Unveils COSMART AVA at the 14th Annual Sales Force Effectiveness and Digital Marketing in Pharma Summit Berlin, 16th October 2024 Vivanti